We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





New COVID-19 Test is Fast, Efficient, Accurate and Unprecedentedly Sensitive

By LabMedica International staff writers
Posted on 22 Jul 2022

As the BA. More...

5 omicron variant continues to spread, health experts are increasingly preparing for a future in which such COVID-19 variants emerge, surge and recede similar to seasonal flu. An important part of staying on top of these changes will be the ability to quickly monitor the virus at a "population scale," an effort that will require accurate and ultra-fast testing. Now, a new biosensor that is currently being developed has the potential to achieve the speed and efficiency required for the future of COVID-19 testing.

The COVID-19 test developed by researchers from the School of Science at IUPUI (Indianapolis, IN, USA) can currently analyze samples from 96 individuals in under three hours. In terms of efficiency, the system requires only 10 microliters of blood. By comparison, a typical blood panel order by a primary-care physician collects 10 milliliters of blood - over 1,000 times more. The sensor also works with other sample types, such as saliva, although the study was conducted using blood since it is the most complex bodily fluid and therefore, the best indicator of a sensor's accuracy.

For the study, the researchers tested 216 blood samples: 141 samples from patients with COVID-19 and 75 healthy control samples. Based upon a blind analysis, the researchers found their biosensor's accuracy rate was 100% and its specificity rate was 90%. In other words, the sensor never reported a false negative and only reported a false positive in 1 out of 10 samples. For the purposes of public safety, the absence of false negatives is more important than false positives, because a person with a false negative may unknowingly infect others, whereas a person with a false positive is not a danger.

Additionally, the sensor was found to be highly accurate at measuring the body's COVID-19 antibody concentration. This is because it detects not only the virus's spike protein but also the proteins created by the body to protect against the virus - immunoglobin G, or IgG. The ability to measure COVID-19 antibodies is significant because many COVI9-19 antibody tests currently approved under the FDA's emergency use authorization do not provide specific antibody counts, despite the fact that this number indicates the strength of a person's immunity to infection. To achieve its results, the biosensor uses chemically synthesized gold triangular nanoprisms, which provide a uniquely powerful optical response to even minuscule amounts of IgG. It also means the sensor can detect antibodies in the earliest stages of infection.

"Everyone is chasing high-throughput testing; this type of high-speed analysis is essential to the future of the fight against COVID-19," said Rajesh Sardar, a professor of chemistry and chemical biology in the School of Science, who led the development. "There are many advantages to our technology in particular: It's fast, efficient, accurate and unprecedentedly sensitive."

"Accurately measuring patients' immunity levels will be critical to protecting against COVID-19 going forward," added Sardar. "This research is about preparing for the future."

Related Links:
IUPUI 


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.